Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Jernberg

Showing results (171-180 of 345) with videos related to

Pageof 35
Sort By:
European Heart Journal. Acute Cardiovascular Care|October 18, 2024
Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trialPhilip Leissner, Katarina Mars, Sophia Humphries, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 31, 2020
Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarctionMarco Trevisan, Edouard L Fu, Karolina Szummer, et al.
ESC Heart Failure|December 1, 2020
Adherence to beta-blockers and long-term risk of heart failure and mortality after a myocardial infarctionLiyew Desta, Masih Khedri, Tomas Jernberg, et al.
BMJ (Clinical Research Ed.)|August 9, 2015
Comparison of hospital variation in acute myocardial infarction care and outcome between Sweden and United Kingdom: population based cohort study using nationwide clinical registriesSheng-Chia Chung, Johan Sundström, Chris P Gale, et al.
European Journal of Preventive Cardiology|July 11, 2025
Severe-Extensive Coronary Atherosclerosis in Low-Risk Individuals and Absence of Coronary Atherosclerosis in High-Risk Individuals: The SCAPIS Extremes ProjectMadeleine Johansson, Göran Bergström, Tomas Jernberg, et al.
Circulation|July 17, 2023
Socioeconomic Disparities and Mediators for Recurrent Atherosclerotic Cardiovascular Disease Events After a First Myocardial InfarctionJoel Ohm, Ralf Kuja-Halkola, Anna Warnqvist, et al.
Atherosclerosis|July 29, 2025
Different plasma biomarker patterns associated with coronary atherosclerosis in low- versus high-risk individuals - an observational cross-sectional studySofia Cederström, Yunzhang Wang, Pia Lundman, et al.
Journal of the American Heart Association|May 17, 2021
Comparing Effect Estimates in Randomized Trials and Observational Studies From the Same Population: An Application to Percutaneous Coronary InterventionAnthony A Matthews, Karolina Szummer, Issa J Dahabreh, et al.
Plos One|March 8, 2022
The value of combining individual and small area sociodemographic data for assessing and handling selective participation in cohort studies: Evidence from the Swedish CardioPulmonary bioImage StudyCarl Bonander, Anton Nilsson, Jonas Björk, et al.
Heart (British Cardiac Society)|August 31, 2010
The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART)Tomas Jernberg, Mona F Attebring, Kristina Hambraeus, et al.
Pageof 35

Showing results (171-180 of 345) with videos related to

Sort By:
Pageof 35
European Heart Journal. Acute Cardiovascular Care|October 18, 2024
Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trialPhilip Leissner, Katarina Mars, Sophia Humphries, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 31, 2020
Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarctionMarco Trevisan, Edouard L Fu, Karolina Szummer, et al.
ESC Heart Failure|December 1, 2020
Adherence to beta-blockers and long-term risk of heart failure and mortality after a myocardial infarctionLiyew Desta, Masih Khedri, Tomas Jernberg, et al.
BMJ (Clinical Research Ed.)|August 9, 2015
Comparison of hospital variation in acute myocardial infarction care and outcome between Sweden and United Kingdom: population based cohort study using nationwide clinical registriesSheng-Chia Chung, Johan Sundström, Chris P Gale, et al.
European Journal of Preventive Cardiology|July 11, 2025
Severe-Extensive Coronary Atherosclerosis in Low-Risk Individuals and Absence of Coronary Atherosclerosis in High-Risk Individuals: The SCAPIS Extremes ProjectMadeleine Johansson, Göran Bergström, Tomas Jernberg, et al.
Circulation|July 17, 2023
Socioeconomic Disparities and Mediators for Recurrent Atherosclerotic Cardiovascular Disease Events After a First Myocardial InfarctionJoel Ohm, Ralf Kuja-Halkola, Anna Warnqvist, et al.
Atherosclerosis|July 29, 2025
Different plasma biomarker patterns associated with coronary atherosclerosis in low- versus high-risk individuals - an observational cross-sectional studySofia Cederström, Yunzhang Wang, Pia Lundman, et al.
Journal of the American Heart Association|May 17, 2021
Comparing Effect Estimates in Randomized Trials and Observational Studies From the Same Population: An Application to Percutaneous Coronary InterventionAnthony A Matthews, Karolina Szummer, Issa J Dahabreh, et al.
Plos One|March 8, 2022
The value of combining individual and small area sociodemographic data for assessing and handling selective participation in cohort studies: Evidence from the Swedish CardioPulmonary bioImage StudyCarl Bonander, Anton Nilsson, Jonas Björk, et al.
Heart (British Cardiac Society)|August 31, 2010
The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART)Tomas Jernberg, Mona F Attebring, Kristina Hambraeus, et al.
Pageof 35